Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2023-01-04 00:00:00 ET · period of report 2023-01-03 · accession 0001209191-23-000870 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-04 | 2023-01-03 | AXSM | Coleman Mark | Dir | M - OptEx | $1.30 | +17.5K | 25.1K | +230% | +$22.8K |
| D | 2023-01-04 | 2023-01-03 | AXSM | Coleman Mark | Dir | M - OptEx | $0.00 | -17.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-03 | M | A | 17,501 | $1.30 | 25,097 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-01-03 | M | D | 17,501 | $0.00 | 0 | D | $1.30 · 2013-03-22 to 2023-03-21 | 17,501 Common Stock |